Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial
- 1 April 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Cardiovascular Translational Research
- Vol. 9 (3), 202-213
- https://doi.org/10.1007/s12265-016-9686-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Endomyocardial Implantation of Autologous Bone Marrow Mononuclear Cells in Advanced Ischemic Heart Failure: a Randomized Placebo-Controlled Trial (END-HF)Journal of Cardiovascular Translational Research, 2014
- Renin Inhibition Improves the Survival of Mesenchymal Stromal Cells in a Mouse Model of Myocardial InfarctionJournal of Cardiovascular Translational Research, 2014
- Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass GraftingCirculation Research, 2014
- The Celution®System: Automated Processing of Adipose-Derived Regenerative Cells in a Functionally Closed SystemAdvances in Wound Care, 2014
- Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac FunctionCirculation Research, 2013
- Bioenergetic and Functional Consequences of Cellular TherapyCirculation Research, 2012
- Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and DifferentiationCirculation Research, 2010
- Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2008
- Molecular Mechanisms Underlying the Transition of Cardiac Hypertrophy to Heart FailureCirculation Journal, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006